Description

AOD 9604 is a modified peptide fragment of human growth hormone (HGH), specifically corresponding to amino acids 176–191 of the hormone. It has been developed and studied in research settings for its potential role in lipid metabolism and fat regulation, without directly influencing many of the growth-related pathways typically associated with full growth hormone activity.

Scientific studies have explored how AOD 9604 may interact with biological mechanisms involved in lipolysis (fat breakdown) and inhibition of lipogenesis (fat storage). These pathways are central to metabolic research focused on adipose tissue regulation and energy balance.

Preclinical and experimental studies have examined the peptide’s influence on metabolic signaling pathways related to fat metabolism and body composition. Because of its specific targeting of fat-related metabolic processes, AOD 9604 has attracted attention in scientific investigations exploring obesity, metabolic function, and adipose tissue biology.

Ongoing research continues to evaluate the molecular mechanisms through which AOD 9604 interacts with metabolic pathways and lipid-regulating systems.

Disclaimer:
This product is intended strictly for laboratory research purposes only. It is not approved for human consumption, medical use, or therapeutic applications.